Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
Efthalia Angelopoulou, Yam Nath Paudel, Sokratis G. Papageorgiou, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 175-175
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease
Yasemin Açar, Duygu Ağagündüz, Paola De Cicco, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115788-115788
Open Access | Times Cited: 66
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions
Stacey A. Sakowski, Emily J. Koubek, Kevin S. Chen, et al.
Annals of Neurology (2024) Vol. 95, Iss. 4, pp. 635-652
Open Access | Times Cited: 17
Epidemiology of Parkinson’s Disease: An Update
Juan R. Deliz, Caroline M. Tanner, Paulina González-Latapí
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 6, pp. 163-179
Closed Access | Times Cited: 13
LINC02282 promotes DNA methylation of TRIM6 by recruiting DNMTs to inhibit the progression of Parkinson's disease
Lu Han, Chuansheng Zhao, Jin Feng, et al.
Brain Research Bulletin (2025), pp. 111224-111224
Open Access | Times Cited: 1
Synucleins: New Data on Misfolding, Aggregation and Role in Diseases
Andrei Surguchov, Alexei Surguchev
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3241-3241
Open Access | Times Cited: 43
Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
Maria Tsalenchuk, Steve Gentleman, Sarah J. Marzi
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Defining Parkinson’s Disease: Past and Future
Kristína Kulcsárová, Matěj Škorvánek, Ronald B. Postuma, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S257-S271
Open Access | Times Cited: 8
DNA methylation as a mediator of genetic and environmental influences on Parkinson’s disease susceptibility: Impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenome
Samantha L. Schaffner, Michael S. Kobor
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 29
Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
Efthalia Angelopoulou, Efstratios‐Stylianos Pyrgelis, Christina Piperi
Molecules (2022) Vol. 27, Iss. 23, pp. 8448-8448
Open Access | Times Cited: 27
α-Synuclein and Mechanisms of Epigenetic Regulation
Andrei Surguchov
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 150-150
Open Access | Times Cited: 20
The Role of Hydrogen Sulfide (H2S) in Epigenetic Regulation of Neurodegenerative Diseases: A Systematic Review
Bombonica Gabriela Dogaru, Constantin Munteanu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12555-12555
Open Access | Times Cited: 17
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 474-474
Open Access | Times Cited: 6
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 5
The rise of Parkinson’s disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and “eat, move, sleep” lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand
Roongroj Bhidayasiri, Jirada Sringean, Saisamorn Phumphid, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
Epigenome‐wide association study, meta‐analysis, and multiscore profiling of whole blood in Parkinson's disease
Ingeborg Haugesag Lie, Manuela Tan, Maren Stolp Andersen, et al.
Annals of Clinical and Translational Neurology (2025)
Open Access
Mechanism of arsenic regulation of mitochondrial damage and autophagy induced synaptic damage through SIRT1 and protective effect of melatonin
Xiaoli Zhang, Jing Wang, Mingjie Zhu, et al.
Chemico-Biological Interactions (2025), pp. 111461-111461
Closed Access
Effect Modification between Genes and Environment and Parkinson's Disease Risk
María Teresa Periñán, Kajsa Brolin, Sara Bandrés‐Ciga, et al.
Annals of Neurology (2022) Vol. 92, Iss. 5, pp. 715-724
Open Access | Times Cited: 23
A Machine Learning Approach to Parkinson’s Disease Blood Transcriptomics
Ester Pantaleo, A. Monaco, Nicola Amoroso, et al.
Genes (2022) Vol. 13, Iss. 5, pp. 727-727
Open Access | Times Cited: 19
Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease
Liana Shvachiy, Vera Geraldes, Tiago F. Outeiro
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 4-6, pp. 321-335
Closed Access | Times Cited: 11
The Role of miR-128 in Neurodegenerative Diseases
Marika Lanza, Salvatore Cuzzocrea, Salvatore Oddo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6024-6024
Open Access | Times Cited: 11
Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson’s disease
Samantha L. Schaffner, William Casazza, Fanny Artaud, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
Francesco Cavallieri, Rubens Gisbert Cury, Thiago Gonçalves Guimarães, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 764-764
Open Access | Times Cited: 9
An Interpretable Deep Learning Optimized Wearable Daily Detection System for Parkinson’s Disease
Min Chen, Zhanfang Sun, Xin Tao, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering (2023) Vol. 31, pp. 3937-3946
Open Access | Times Cited: 7
Nuclear DNA and Mitochondrial Damage of the Cooked Meat Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Human Neuroblastoma Cells
Medjda Bellamri, Kyle Brandt, Kari Cammerrer, et al.
Chemical Research in Toxicology (2023) Vol. 36, Iss. 8, pp. 1361-1373
Open Access | Times Cited: 6
Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
Efthalia Angelopoulou, Efstratios‐Stylianos Pyrgelis, Chetana Ahire, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1257-1257
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top